Article

A Clinical and Molecular Comparative Analysis of KRAS Exon 2 and KRAS Non-Exon 2 Mutated Colorectal Cancer

2026-05-28

Abstract excerpt

<h4>Background: </h4> Mutations in the KRAS oncogene occur in approximately 40% of colorectal cancers, predominantly within exon 2. Non-exon 2 mutations are less common and remain poorly characterized in terms of their clinical and biological significance. Systemic inflammatory markers are well-established prognostic indicators in colorectal cancer, yet whether their prognostic value differs across KRAS mutation s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 38502e64-9b3c-56fb-ae51-0ec5107161c2
DOI: 10.20944/preprints202605.1996.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Clinical and Molecular Comparative Analysis of KRAS Exon 2 and KRAS Non-Exon 2 Mutated Colorectal CancerDOI 10.20944/preprints202605.1996.v1Read

Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis.Semantic proximity Read

Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients.Semantic proximity Read

Prognostic Value of KRAS Exon-specific Mutations in Patients With Colorectal Cancer.Semantic proximity Read

Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.Semantic proximity Read

KRAS, APC, and TP53 mutations define opposing immune archetypes in stage III colorectal cancerSemantic proximity Read

KRAS mutation and its association with clinicopathological features of colorectal cancer patients in Africa: a systematic review and meta-analysis.Semantic proximity Read

The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal CancerSemantic proximity Read

Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal CancerSemantic proximity Read

KRAS Mutation Status as a Prognostic Marker and Predictor of Therapy Response in Colorectal Cancer: an NCDB Analysis.Semantic proximity Read

Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal CancerSemantic proximity Read

Relationship Between KRAS Gene Mutation Status and Clinicopathological Features of Colorectal Cancer Patients in MakassarSemantic proximity Read

Prognostic value of KRAS exon 2, exon 3 and exon 4 mutations in colorectal cancer patientsSemantic proximity Read